Published in Biochemistry on November 18, 1997
Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism. Proc Natl Acad Sci U S A (1998) 3.31
Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. J Mol Biol (2008) 2.88
The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis. J Virol (2000) 1.84
Structural basis of HIV-1 resistance to AZT by excision. Nat Struct Mol Biol (2010) 1.50
Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance. EMBO J (2000) 1.40
Nucleotide-dependent conformational change governs specificity and analog discrimination by HIV reverse transcriptase. Proc Natl Acad Sci U S A (2010) 1.31
Relationship between antiviral activity and host toxicity: comparison of the incorporation efficiencies of 2',3'-dideoxy-5-fluoro-3'-thiacytidine-triphosphate analogs by human immunodeficiency virus type 1 reverse transcriptase and human mitochondrial DNA polymerase. Antimicrob Agents Chemother (2004) 1.27
Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase. Viruses (2010) 1.24
ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (2002) 1.23
Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine. Antimicrob Agents Chemother (2001) 1.17
DNA polymerases as therapeutic targets. Biochemistry (2008) 1.12
Mechanistic differences in RNA-dependent DNA polymerization and fidelity between murine leukemia virus and HIV-1 reverse transcriptases. J Biol Chem (2005) 1.10
Role of induced fit in limiting discrimination against AZT by HIV reverse transcriptase. Biochemistry (2011) 1.05
Mechanism of inhibition of the human immunodeficiency virus type 1 reverse transcriptase by d4TTP: an equivalent incorporation efficiency relative to the natural substrate dTTP. Antimicrob Agents Chemother (2000) 1.03
Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir. Antimicrob Agents Chemother (2007) 0.99
Pre-steady-state kinetic analysis of the incorporation of anti-HIV nucleotide analogs catalyzed by human X- and Y-family DNA polymerases. Antimicrob Agents Chemother (2010) 0.89
Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase by a stavudine analogue, 4'-ethynyl stavudine triphosphate. Antimicrob Agents Chemother (2008) 0.88
NTP-mediated nucleotide excision activity of hepatitis C virus RNA-dependent RNA polymerase. Proc Natl Acad Sci U S A (2013) 0.86
Mechanistic and Kinetic Differences between Reverse Transcriptases of Vpx Coding and Non-coding Lentiviruses. J Biol Chem (2015) 0.84
K65R and K65A substitutions in HIV-1 reverse transcriptase enhance polymerase fidelity by decreasing both dNTP misinsertion and mispaired primer extension efficiencies. J Mol Biol (2010) 0.81
Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy. J Med Chem (2013) 0.80
Insights into the Molecular Mechanism of Polymerization and Nucleoside Reverse Transcriptase Inhibitor Incorporation by Human PrimPol. Antimicrob Agents Chemother (2015) 0.77
Analysis of the Zidovudine Resistance Mutations T215Y, M41L, and L210W in HIV-1 Reverse Transcriptase. Antimicrob Agents Chemother (2015) 0.77
A mechanistic and structural investigation of modified derivatives of the diaryltriazine class of NNRTIs targeting HIV-1 reverse transcriptase. Biochim Biophys Acta (2014) 0.76
A new general method for simultaneous fitting of temperature and concentration dependence of reaction rates yields kinetic and thermodynamic parameters for HIV reverse transcriptase specificity. J Biol Chem (2017) 0.75
Mechanism and fidelity of HIV reverse transcriptase. J Biol Chem (1992) 4.57
Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors. Science (1995) 3.60
Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J Biol Chem (2001) 2.31
Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci U S A (1993) 2.16
Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase. Biochemistry (1999) 1.45
Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs. J Biol Chem (2001) 1.31
Mechanistic studies comparing the incorporation of (+) and (-) isomers of 3TCTP by HIV-1 reverse transcriptase. Biochemistry (1999) 1.30
Structure and topological symmetry of the glyphosate target 5-enolpyruvylshikimate-3-phosphate synthase: a distinctive protein fold. Proc Natl Acad Sci U S A (1991) 1.29
Y265H mutator mutant of DNA polymerase beta. Proper teometric alignment is critical for fidelity. J Biol Chem (2001) 1.27
Tissue-specific induction of murine glutathione transferase mRNAs by butylated hydroxyanisole. J Biol Chem (1988) 1.27
Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine. Antimicrob Agents Chemother (2001) 1.17
Pre-steady-state kinetic analysis of the trichodiene synthase reaction pathway. Biochemistry (1997) 1.15
Detection and characterization of a phospholactoyl-enzyme adduct in the reaction catalyzed by UDP-N-acetylglucosamine enolpyruvoyl transferase, MurZ. Biochemistry (1994) 1.13
Surface point mutations that significantly alter the structure and stability of a protein's denatured state. Protein Sci (1996) 1.09
HIV-1 reverse transcriptase resistance to nonnucleoside inhibitors. Biochemistry (1996) 1.06
Loop closure and intersubunit communication in tryptophan synthase. Biochemistry (1998) 1.05
Mechanism of inhibition of the human immunodeficiency virus type 1 reverse transcriptase by d4TTP: an equivalent incorporation efficiency relative to the natural substrate dTTP. Antimicrob Agents Chemother (2000) 1.03
Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase. Clin Cancer Res (2001) 1.02
RNA dependent DNA replication fidelity of HIV-1 reverse transcriptase: evidence of discrimination between DNA and RNA substrates. Biochemistry (1997) 1.02
Mechanistic studies show that (-)-FTC-TP is a better inhibitor of HIV-1 reverse transcriptase than 3TC-TP. FASEB J (1999) 1.00
Substrate channeling and domain-domain interactions in bifunctional thymidylate synthase-dihydrofolate reductase. Biochemistry (1998) 0.99
Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals. Cancer Res (2001) 0.97
Leishmania major pteridine reductase 1 belongs to the short chain dehydrogenase family: stereochemical and kinetic evidence. Biochemistry (1998) 0.92
Using loop length variants to dissect the folding pathway of a four-helix-bundle protein. J Mol Biol (1999) 0.91
Intersubunit communication in tryptophan synthase by carbon-13 and fluorine-19 REDOR NMR. Biochemistry (1996) 0.91
Generalized measurable ignition criterion for inertial confinement fusion. Phys Rev Lett (2010) 0.90
Detection and identification of transient enzyme intermediates using rapid mixing, pulsed-flow electrospray mass spectrometry. Biochemistry (1997) 0.90
Speeding up protein folding: mutations that increase the rate at which Rop folds and unfolds by over four orders of magnitude. Fold Des (1997) 0.89
Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis. Aliment Pharmacol Ther (2014) 0.89
Insights into the HER-2 receptor tyrosine kinase mechanism and substrate specificity using a transient kinetic analysis. Biochemistry (2000) 0.87
Initiation of minus-strand DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. Biochemistry (1999) 0.87
Linking genomics to immunotherapy by reverse immunology--'immunomics' in the new millennium. Curr Mol Med (2001) 0.85
Reevaluating glyphosate as a transition-state inhibitor of EPSP synthase: identification of an EPSP synthase.EPSP.glyphosate ternary complex. Biochemistry (1995) 0.85
Mechanistic studies to understand the inhibition of wild type and mutant HIV-1 reverse transcriptase by Carbovir-triphosphate. Nucleosides Nucleotides Nucleic Acids (2001) 0.85
Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients. Clin Exp Immunol (2005) 0.85
Catalytic mechanism of Kdo8P synthase: transient kinetic studies and evaluation of a putative reaction intermediate. Biochemistry (1998) 0.85
Crystallographic studies of phosphonate-based alpha-reaction transition-state analogues complexed to tryptophan synthase. Biochemistry (1999) 0.84
Duration of Alphavirus neutralizing antibody in naturally infected birds. Am J Trop Med Hyg (1988) 0.84
Implication of the tRNA initiation step for human immunodeficiency virus type 1 reverse transcriptase in the mechanism of 3'-azido-3'-deoxythymidine (AZT) resistance. Biochemistry (1998) 0.84
Expression of human cyclophilin-40 and the effect of the His141-->Trp mutation on catalysis and cyclosporin A binding. Eur J Biochem (1995) 0.83
Structure and functional relationships in human pur H. Adv Exp Med Biol (1998) 0.82
Structural and kinetic analysis of a channel-impaired mutant of tryptophan synthase. J Biol Chem (1994) 0.82
Energetics of S-adenosylmethionine synthetase catalysis. Biochemistry (2000) 0.81
Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses. Biochem Pharmacol (1985) 0.81
Kinetic reaction scheme for the dihydrofolate reductase domain of the bifunctional thymidylate synthase-dihydrofolate reductase from Leishmania major. Biochemistry (1998) 0.80
An analysis of the catalytic cycle of HIV-1 reverse transcriptase: opportunities for chemotherapeutic intervention based on enzyme inhibition. Curr Pharm Des (2000) 0.80
Deoxythioguanosine triphosphate impairs HIV replication: a new mechanism for an old drug. FASEB J (2001) 0.79
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens. Vox Sang (2001) 0.78
Operative treatment of congenital pseudarthrosis of the tibia. Acta Orthop Scand (1974) 0.75
ECT seizure classification. Can J Anaesth (1998) 0.75
Conformational requirements of alpha 2-adrenergic receptors. Mol Pharmacol (1982) 0.75
A review of succinylcholine-induced apnea. AANA J (1982) 0.75
A Logarithmic Complexity Floating Frame of Reference Formulation with Interpolating Splines for Articulated Multi-Flexible-Body Dynamics. Int J Non Linear Mech (2013) 0.75
Shock ignition of thermonuclear fuel with high areal density. Phys Rev Lett (2007) 0.75
The catalytic mechanism of EPSP synthase revisited. Biochemistry (1999) 0.75
High-rhoR implosions for fast-ignition fuel assembly. Phys Rev Lett (2007) 0.75
Transport and expression of class I MHC glycoproteins in an antigen-processing mutant cell line. Cold Spring Harb Symp Quant Biol (1992) 0.75